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The A2V mutation as a new tool 
for hindering Aβ aggregation: A 
neutron and x-ray diffraction study
Laura Cantu’1, Laura Colombo2, Tatiana Stoilova2, Bruno Demé3, Hideyo Inouye4, Rachel 
Booth5, Valeria Rondelli1, Giuseppe Di Fede6, Fabrizio Tagliavini6, Elena Del Favero1, Daniel A. 
Kirschner5 & Mario Salmona2
We have described a novel C-to-T mutation in the APP gene that corresponds to an alanine to valine 
substitution at position 673 in APP (A673V), or position 2 of the amyloid-β (Aβ) sequence. This 
mutation is associated with the early onset of AD-type dementia in homozygous individuals, whereas 
it has a protective effect in the heterozygous state. Correspondingly, we observed differences in the 
aggregation properties of the wild-type and mutated Aβ peptides and their mixture. We have carried 
out neutron diffraction (ND) and x-ray diffraction (XRD) experiments on magnetically-oriented fibers of 
Aβ1-28WT and its variant Aβ1-28A2V. The orientation propensity was higher for Aβ1-28A2V suggesting 
that it promotes the formation of fibrillar assemblies. The diffraction patterns by Aβ1-28WT and Aβ1-
28A2V assemblies differed in shape and position of the equatorial reflections, suggesting that the two 
peptides adopt distinct lateral packing of the diffracting units. The diffraction patterns from a mixture 
of the two peptides differed from those of the single components, indicating the presence of structural 
interference during assembly and orientation. The lowest orientation propensity was observed for 
a mixture of Aβ1-28WT and a short N-terminal fragment, Aβ1-6A2V, which supports a role of Aβ’s 
N-terminal domain in amyloid fibril formation.
Alzheimer’s disease (AD), the most frequent form of dementia in the elderly, is defined neuropathologically by 
extracellular amyloid plaques and intraneuronal neurofibrillary tangles in limbic and cortical regions of brain1. 
The principal pathological hallmark of AD is the accumulation of amyloid-β (Aβ) peptides that are misfolded, and 
assemble as oligomers and fibrils2–4. The peptides Aβ1-40 and Aβ1-42 are generated by proteolytic cleavage of a 
large (695/770 amino acids) type 1 transmembrane glycoprotein known as amyloid β precursor protein (APP)2, 5. 
Aggregated Aβ species are believed to trigger a cascade of events that lead to protein tau hyperphosphorylation, 
misfolding, and assembly into abnormal filaments of neurofibrillary tangles, disruption of the neuronal cytoskel-
eton, widespread synaptic loss, and neurodegeneration6, 7. This cascade appears to offer a number of points at 
which to interfere with the sequence of pathology; however, to date all strategies have faced serious hurdles in 
clinical application, where the tested drugs have been ineffective or caused severe adverse events8, 9. Thus, there is 
still an urgent need for safe and effective molecules for AD treatment.
We have previously identified an APP gene mutation that is consistent with a recessive Mendelian trait of 
inheritance, causing disease only in the homozygous state and not in heterozygous carriers even when elderly10. 
The mutation consists of a C-to-T transition generating an A-to-V substitution at position 673 of APP, and in 
position 2 of Aβ. In vitro studies with fibroblasts from patients and controls, APP transfected cells and syn-
thetic Aβ peptides show that the A673V APP mutation has two pathogenic effects: (i) shifting APP processing 
toward the amyloidogenic pathway with increased Aβ production, and (ii) enhancing the aggregation and fibril-
logenic properties of Aβ. However, the interaction between mutant and wild-type Aβ interferes with nucleation 
or nucleation-dependent Aβ polymerization, or both, hindering amyloidogenesis and Aβ-related neurotoxicity, 
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and thus protecting heterozygous carriers from disease10, 11. Correspondingly, we also observed consistent dif-
ferences in the early-stage aggregation process of the wild-type and mutated Aβ peptides and their mixture12. 
The identification of a mutated Aβ sequence which acts in a dominant-negative fashion on amyloidogenesis 
has important implications for potential treatment of both the sporadic and familial forms of AD10, 13. Distinct 
from previous approaches based on theoretical grounds, our novel strategy stems from the clinical observa-
tion that a naturally-occurring variant of Aβ protects from disease10, 14, 15. Notably, in prion protein involved 
Creutzfeld-Jacob-Disease (CJD), variability has been linked to genetic factors and to the chemico-physical prop-
erties of PrPSc. Different PrPSc “conformers” and distinct polymorphisms at codon 129 site encoding methionine 
(M) or valine (V), may modulate the susceptibility, the incubation period and the clinical and pathological fea-
tures of the disease, resulting in the occurrence of different CJD phenotypes16, 17.
Preliminary to designing an inhibitor of Aβ aggregation based on the mutated Aβ sequence, we synthesized a 
short peptide homologous to residues 1–6 of Aβ with and without the A2V substitution and tested their ability to 
bind preformed Aβ fibrils and to inhibit amyloidogenesis. The mutated but not the wild-type six-mer peptide was 
found to retain the anti-amyloidogenic properties of the parent full-length Aβ13. Molecular dynamics simulations 
suggest that this property may be related to the structural flexibility of the peptide which adopts dynamically 
“closed” and “open” configurations, at variance with the wild-type sequence which is characterized by a “closed” 
structure11. The labile structure of the mutated hexapeptide may facilitate heterotypic interaction with Aβ, thereby 
hindering Aβ assembly. These preliminary experiments offered a proof of concept and provide a foundation for 
the rational design of therapeutic agents based on Aβ fragments with the A2V mutation and peptido-mimetic 
molecules retaining the key functional properties of the mutated Aβ. In light of these observations the main ques-
tions still to be answered are: (i) the structural characterization of macromolecular assemblies of Aβ peptides with 
the A2V mutation, and (ii) the biochemical basis for the aggressiveness of the A2V mutation.
Results and Discussion
A significant aspect in AD therapeutics is the different response to treatment of the patients in clinical trials. This 
may be ascribed to amyloid-β fibril polymorphism that is correlated with subgroups of disease neuropathological 
and biochemical profiles, and pathogenic pathways18. Understanding the molecular basis of AD heterogeneity 
may help design more appropriate therapies based on recognition of different target phenotypes. Therefore, the 
identification and categorization of AD subtypes is now becoming an urgent need for its potential diagnostic and 
therapeutic implications.
Here we report on and analyze the diffraction patterns of Aβ1-28 wild type (WT) the mutated peptide Aβ1-
28A2V (A2V), their 1:1 molar mixture (WT:A2V) and the mixture of WT with the short mutated C-terminal 
sequence Aβ1-6A2V (1-6A2V). All peptides were slowly dried on a flat support under a static magnetic field. 
Morphological characterization by microscopy was performed under different experimental conditions, i.e., 
on deposited samples and as reconstituted in aqueous solution. Diffraction from WT and A2V in the form of 
lyophilized powder was also recorded.
The wide-angle x-ray powder diffraction patterns of lyophilized WT and A2V (Supplementary Information, 
Fig. SI1) showed two spherically-averaged reflections, at spacings of ~10 Å and ~4.7 Å, characteristic of the inter-
sheet and hydrogen-bonding distances, respectively, for a β-sheet conformation. Moreover, like the fibril-forming 
fragments Aβ1-40 and Aβ1-42 of APP, both the wild type and A2V sequences for the 28 amino acid-long frag-
ment of Aβ1-40/42, assembled as fibrils. Analysis of the peak positions and integral line widths of the x-ray pat-
terns showed that the assemblies formed by the two peptides have similar local packing and similar 30–40 Å-sizes 
or coherence lengths for their diffracting regions.
To prepare amyloid fibrils with higher degree of macroscopic axial orientation, concentrated solutions (10 mg/
mL) of the peptides WT, A2V, WT:A2V, and WT:1-6A2V in quartz cells (Supplementary Information, Fig. SI2) 
were aligned while drying in the presence of a magnetic field. As previously described, molecules that possess 
diamagnetic anisotropy will orient in a constant magnetic field (B)19; for polypeptides, the peptide bonds and 
aromatic residues are the major sources of anisotropy: examples include collagen19, diphenylalanine tubes20 and 
Aβ peptides21. When the orienting energy is sufficiently greater than the disorienting thermal energy (kT) due 
to Brownian motion, a high degree of orientation will occur19, and stronger magnetic fields will induce better 
alignment. For our peptides, we confirmed by polarized light microscopy (Fig. 1A) and AFM (Fig. 1B) that a 
7 T magnetic field was sufficient to induce alignment of WT and A2V. The dried, closely-packed fibrils formed 
by A2V were highly-aligned, whereas WT and the mixture WT:A2V formed two populations of fibrils, oriented 
~30–40° to one another. Moreover, co-incubation of WT and 1-6A2V produced poorly- or non-oriented, seem-
ingly non-fibrillar assemblies.
To assess the mesoscale organization (i.e. between the atomic and macrolevel dimensions) of the assemblies 
that had been visualized above, we humidified the samples by equilibration against an atmosphere of 100% D2O 
(14 days at room temperature) and then examined them using x-ray (XRD; Fig. 1C) and neutron (ND; Fig. 1D) 
scattering (Sample Set I). ND measurements were repeated on independently prepared samples (Sample Set II) 
and gave similar results (Supplementary Information, Fig. SI3). The diffraction results were consistent with the 
qualitative observations about fibril orientation made by polarized light microscopy, and gave quantitative infor-
mation about the mesoscale structure of the aggregates.
Both ND and XRD showed that the four kinds of samples differed in the shape and angular distribution of 
their diffracted intensities.
For A2V, these techniques revealed relatively sharp, highly-oriented scattering consisting of two strong inten-
sity maxima extending from the center of the pattern along the equator, which is consistent with well-formed 
fibers that are predominantly oriented along the magnetic field (Fig. 1C and D, second column). For WT, by 
contrast, the diffraction patterns (Fig. 1C and D, first column) were more complex in appearance, in that the 
predominant intensity maximum was more arced than for A2V, indicating less well-oriented fibers. Weaker 
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lateral interactions between fibrils could account for greater disorientation; and the doubled maximum indicates 
a double-orientation of fibers (31° tilt) which could arise from twisting, completely absent in A2V. For WT:A2V 
(the 1:1 molar ratio mixture of the two peptides), both XRD and ND patterns (Fig. 1C and D, third column) 
showed broad, butterfly-like crisscross scatter (27° tilt). Finally, for WT:1-6A2V (the 1:4 molar ratio mixture of 
WT and 1-6A2V), only very weak XRD and ND scattering was detected (Fig. 1C and D, fourth column), and this 
was mostly concentrated adjacent to the beam stop, and had low or no directionality, indicating that the scattering 
objects were mostly randomly distributed. Thus, the amount of highly-organized, well-ordered (or crystalline) 
material varied considerably among the four types of samples. The good agreement between ND and XRD pat-
terns (see also below), despite the ∼100 fold size difference in their beam cross-section (∼1 cm2 vs. <1 mm2, 
respectively) suggests that the observed features are widespread over the entire sample. For both ND and XRD, 
the absence of meridional reflections in the small-angle region indicated that the scattering objects —i.e., the 
structural units constituting the fibers— resemble elongated solid cylinders. No appreciable periodicity could be 
detected along the axial direction, at least on a length-scale of a few tens of Å. Should the structural unit itself be 
distorted around its axis, any axial periodicity would be obscured by spatial averaging. Therefore, in the following, 
Figure 1. Biophysical characterization of the macromolecular assemblies formed by amyloidogenic peptides: 
WT; A2V; WT:A2V, a 1:1 molar mixture of the WT and A2V peptides; and WT:1-6A2V, a 4:1 molar mixture 
of the WT and hexapeptide 1-6A2V. (A) Polarized light microscopy. Scale bar: 500 nm. (B) AFM. Scale bar: 
5 µm (C) Small-angle x-ray diffraction. (Data collected at ESRF, Grenoble, FR.) (D) Neutron diffraction. (Data 
collected at ILL, Grenoble, FR.). (E) Intensity of the ND data along the equator. Black line: observed scatter; 
solid and dashed red lines: calculated scatter (see Supplementary Information, Theory) for the size of structural 
unit and its assembly as modeled in (F). (F) The fibrils modeled by solid cylinders arranged as shown (see 
Supplementary Information, Theory). (G) AFM from the samples examined by x-ray and neutron diffraction 
after resuspension in ddH2O. Scale bar: 1 µm. In (A–D), the vertical direction corresponds to the direction of 
the aligning magnetic field used in sample preparation.
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the units were modelled as simple cylinders, and some of the folded polypeptide assumed to be arranged at 
some distance from the fiber axis, as described in the Methods section and in the literature quoted therein. More 
refined models can be found in the literature, offering details of the molecular and even of the single-aminoacid 
arrangement within the aggregates for different amyloidogenic peptides, which are based on molecular sim-
ulation owing to the lack of well developed crystals22, and deducing from NMR results the local contacts and 
proximities23, 24. The present experiments indicate the presence of differences in the mesoscale spatial arrange-
ment of organized units of two variants of an extended Aβ fragment (1–28), including the N-terminal portion, 
and of their mixture. Differences in the interaggregate scale organization could hierarchically reflect differences 
in packing, which may be relevant to the onset and progression of the disease connected to the full-length Aβ 
peptide. Extending our analysis to use highly refined atomic models, developed for other fragments or other 
amyloidogenic peptides and for different purposes is not useful here, as it would require introducing a number 
of additional assumptions and specific parameters at much higher resolution than can be determined with con-
fidence from our current data.
For Sample Set I, the ND and XRD scattering profiles along the equatorial (horizontal) direction (which is 
perpendicular to the fiber axis) showed close agreement between the two techniques (Fig. 2). The diffraction 
patterns for WT showed the main equatorial peak at Q = 0.045 Å−1 (corresponding to ~140 Å in real space), and a 
minor peak at Q = 0.09 Å−1. For A2V a broad intensity maximum extended over a range of a few-hundreds-Å and 
a less intense but sharper intensity maximum was at Q~0.08 Å−1 (corresponding to ~80 Å). The patterns from the 
mixture WT:A2V exhibited two peaks, one of which was similar in position to that of WT. For the mixture WT:1-
6A2V, the peak was very weak, and positioned similar to one of the peaks in WT:A2V. Assuming these peaks arise 
from distances relating to inter-particle interference, then the separation of the scattering objects is largest in 
WT, and smallest in A2V. For WT and A2V, we also observed a weak reflection at Q~0.63 Å−1 (corresponding to 
10 Å), which is the expected intersheet distance for β-sheet arrays. In the two mixed samples, however, a weaker 
peak was also present but for distances <10 Å. The smaller intersheet packing would be accounted for by closer 
packing of apposed β-sheets owing to smaller side chains and/or to a difference in side chain interactions. Table 1 
lists the spacings observed for the reflections for each sample.
As indicated above, the amount of crystallinity among the samples varied. To quantitate the amount of crys-
tallinity, we calculated the relative contribution of fibrils to the total scatter, which included fibrils, oligomers, 
and monomers (Supplementary Information and Table 1). The excess intensity due to the crystallized material, 
based on the assembly of axisymmetric structural units, was compared to the unstructured background. The fibril 
contribution to the scatter from the samples, expressed by the crystallinity parameter p, was largest in WT and 
Figure 2. Comparison of equatorial x-ray (XRD) and neutron diffraction (ND) scatter from the WT, A2V, 
WT:A2V, WT:1-6A2V samples.
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WT:A2V, and smallest in A2V and WT:1-6A2V. The estimated low crystallinity of the A2V sample seems to be 
in contrast with the high extent of fiber formation and alignment otherwise observed. This could be connected to 
the scarce water penetration into the deposited A2V sample, giving rise to lower contrast. In the following we will 
point out further observations in support of this explanation.
Analysis of the equatorial scatter (Fig. 1E) also provided sufficient data to calculate the widths of the struc-
tural units, assumed cylindrical, and of their spatial arrangement (described in the Supplementary Information, 
Theory). The lateral hindrance of the axisymmetric units, which best fit the equatorial diffracted intensities, were 
not the same for the different types of samples. A pictorial sketch is shown in Fig. 1F. For WT, the data were most 
consistent with four units, each 106 Å in diameter, organized on a circle 160 Å in size. For A2V, by contrast, a 
composite structure could be determined, where three narrow units, each 36 Å in diameter, were constituted in 
a 132 Å-size cylindrical volume that in turn was organized with two others onto a circle of diameter 196 Å. The 
equatorial scatter from WT:A2V indicated a superposition of two arrangements, indicating the coexistence of 
different structures. Finally, sample WT:1-6A2V had a very low content of fibrils, the few present retaining some 
common features with WT. In general, the sizes deduced here for the diffracting structural units were consistent 
with previous studies on protofilament or fibrillar, multimeric assemblies by x-ray and neutron solution scattering 
from serum amyloid P25, x-ray fiber diffraction from APP fragments Aβ1-2826 and Aβ1-4021, and solid-state NMR 
data on Aβ1-4027, 28. As already pointed out, direct structural information on lengths shorter than mesoscale are 
beyond the accessible range with the experimental techniques used here. Nonetheless, the calculated numerical 
values and the sketches reported in Fig. 1F can be examined to unveil possible analogies and discrepancies under-
lying the observed packing of variants, refering hierarchically to the mesoscale. In particular, due to the better 
definition of A2V aggregates, a more detailed description was allowed, detecting the existence of a smaller-size 
structural unit as compared to WT, having a size compatible with  a hairpin folded Aβ1-28 fragment22. Molecular 
modeling of this fragment has shown that the secondary structure propensity of the constituent amino acids 
allows for a turn in the intermediate 14–15 position, joining two adjacent sequences each displaying pronounced 
β-strand propensity. Moreover, the A to V substitution in position 2 is found to generate an important change 
in the free energy landscape of the peptide22. Notably, the size of the smallest detected unit in WT is three times 
as large as the one in A2V −106 Å vs 36 Å. Detailed existing models24, 29 address the existence of some general 
packing features shared by all amyloidogenic peptides, independent of their individual configuration. Spatial 
repetition and assembling of subunits is a common structural property, not only on the molecular scale, in the 
formation of β-sheet and in protofibrillar association, but also in lateral association of axially organized subu-
nits, which gives rise to quantized sizes of aggregates. In this context, we then speculate that axially organized 
subunits of the same size (36 Å) are formed in both variants, but show a different ability to establish interactions 
between subunits, with WT arranging in the form of triplet-ribbons, and A2V in the form of triplet-bunches, a 
more condensed structure. This arrangement with a bunched-type cross-section has been observed within the 
polymorphic morphology of amyloid fibers30. A triplet-bunch versus triplet-ribbon packing could also account 
for the apparent higher rigidity of A2V fibers, favouring a compact macroscopic deposition that is precluded from 
twisting, by contrast with WT oriented fibers.
At wide-angles, which corresponds to a length-scale of a few Angstrom, both WT and A2V (Sample Set I) gave 
a distinct sharp meridional reflection. Angular integration of the meridional intensity revealed a peak centered at 
Q = 1.312 Å−1, corresponding in real space to d~4.8 Å, although weaker for the WT sample, confirming that both 
variants form β-sheet structures along the H-bonding direction and are more ordered for A2V. The wide-angle 
diffraction pattern and the angular integrated intensity are shown in Fig. SI4 for the A2V sample. Interestingly, 
the mixtures WT:A2V and WT:1-6A2V did not show this meridional reflection, indicating for their assemblies a 
greater disorder in the H-bonding direction. This finding helps in discriminating that the mixed WT:A2V fibers, 
although constituted by coexisting populations with different mesoscale packing, are truly mixed on the molec-
ular scale with actual structural interference between the two variants. It can be speculated that the starting seed 
of the two populations is determined by either variant. This structural observation on the mixed fibers agrees and 
reinforces a previous finding on mixed oligomers, that they are readily soluble upon dilution, for longer times 
with respect to both constituents10. The absence of wide-angle diffraction from the WT:1-6A2V sample parallels 
the almost total absence of fibers detected in the small-angle profiles.
H-D exchange has been used to probe the core structures for an assortment of amyloid fibrils and protofibrils, 
in relation to the kinetics of molecular recycling within an ensemble of forming fibrils31, and based on the fact 
that the velocity of H-D exchange of the backbone amide hydrogens of Aβ is strongly reduced when monomers 
are incorporated into fibrils32, 33. This “conventional use” of the technique was performed while fibers were put 
in disaggregating solvent (DMSO), in order to follow the amount of free monomers able to leave the aggregated 
structure at different times and conditions. Additionally, we followed the H-D exchange rate on formed deposited 
ND XRD
Peak position on 
equator (Q in Å−1)
Characteristic distance 
in real space (d in Å)
Crystallinity 
p
Peak position on 
equator (Q in Å−1)
Mutual 
orientation (°)
Peak position on meridian 
(Q in Å−1) and [d in Å]
WT 0.045; 0.09 140; 70 0.45 0.044 31° 1.312 [4.79]
A2V 0.013–0.04; 0.08; 0.63 480–160; 80; 10 0.14 0.075 1.312 [4.79]
WT:A2V 0.047 133 0.47 0.044; 0.071 27°
WT:1–6A2V 0.06 105 0.09 0.058
Table 1. Parameters deduced from Neutron and x-ray Diffraction Patterns.
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fibers, in order to assess the accessibility of the aggregated structure and the extent of involvement of amide 
groups in internal engagement.
In the current study we measured the rates of H-D exchange to determine the propensity of the formed fibers 
to interact with solvent (Fig. 3). For WT, at time t = 0, after the system was equilibrated against 100% D2O, the 
intensity of neutron scattering from the predominant peak (Q = 0.045 Å−1) was high; however, upon substitution 
of D2O with H2O, the intensity started decreasing immediately and rapidly and, at the same time, the back-
ground intensity, due to the incoherent scatter by hydrogen incorporated into the sample, increased (Fig. SI6, 
left panel). As no shift in peak position was observed, this diffraction peak likely derives from amide hydrogens. 
These general features were also displayed for A2V (peak position at Q = 0.075 Å−1) and WT:A2V (peak position 
at Q = 0.047 Å−1). By contrast, we observed a difference in extent and kinetics of exchange, indicating that the 
organization within aggregates was not the same among the samples. The rates of H-D substitution for the differ-
ent samples (Fig. 3, middle panel) were compared after normalizing the decay in intensity, I(t)/I0, and showed that 
the D-H exchange had similar kinetics in the WT and A2V assemblies, with characteristic decay times ~2.5 h. For 
the mixture of WT:A2V, however, exchange was faster, with a time of ~1.9 h indicating a weaker involvement of 
hydrogens in inter-aggregate H-bond formation, and greater exposure to the medium. After D-H exchange the 
residual intensity of the predominant peak which, as described above, reflects amide hydrogens was higher for the 
A2V sample (Fig. 3, right panel), indicating that a greater number of hydrogens are protected (or cryptic) within 
the amyloid fibrils, rather than exposed to the surrounding medium. This observation agrees with the ribbon 
versus bunches hypothesis.
Following the neutron diffraction experiments, the samples were resuspended in ddH2O (described in 
Methods) and re-examined by AFM to determine the size of the fibrils (Fig. 1G). The sample containing mixture 
WT:1-6A2V was easily and completely resuspended, more so than WT and mixture WT:A2V. By contrast, sample 
A2V could not be solubilized even after incubation for 3 days. The assemblies of A2V after resuspension were 
large macro-fibrillar complexes, while in the case of WT, both single and twisted macro-fibrils were observed. The 
mixture WT:A2V showed both twisted and single fibrils, most of which were short and/or broken. Finally, the 
mixture WT:1-6A2V showed single fibrils only. The estimated heights of the aggregates were 50–150 Å for WT 
and WT:A2V, ~350 Å for A2V, and 15–25 Å for WT:1–6A2V. The larger value for A2V is consistent with the sizes 
estimated from the low-angle ND and XRD (Fig. 1F). Again, these observations agree with the overall landscape 
presented so far.
Conclusion
Astonishingly different structural features are observed in the aggregated structures of the examined Aβ1-28 
fragments, differing by a single aminoacid (either alanine or valine) in the N-terminal position 2. These variants 
correspond to clearly different neuropathological and biochemical profiles connected to the whole Aβ peptide. 
Differences are found in the mesoscale arrangement, involving the interaction between elementary axial units, 
resulting in fibers of different compactness and solvent accessibility. Close structural interference is found when 
the two variants are mixed, which has a distinctive clinical correlate.
Taken together, these data suggest that the substitution of alanine by valine at position 2 of the amyloidogenic 
peptide affect the lateral interactions between fibrils, promoting a more compact, aligned and uniform structure. 
Further, the structure and characteristics of the mixture WT:1-6A2V indicated that the presence of the short 
N-terminal domain of mutated Aβ1-6A2V could disrupt or prevent inter-fibrillar interactions in the WT.
According to the models proposed based on NMR27, 28, the N-terminal residues are always located at the 
outside of the fibril. Thus, alanine-alanine interaction in WT and valine-valine interactions in A2V should be 
involved in inter-fibrillar interactions and dimerization. The higher degree of orientation in the latter suggests 
Figure 3. Analysis of neutron scattering changes due to H-D exchange in WT, A2V, and WT:A2V samples. 
(Left) Time-dependent change (D-H) in neutron scattering upon replacement of D2O with H2O in the tubular 
reservoir of the sample holder. (Middle) The decay in intensity of the predominant neutron scattering peak, 
I(t)/Io, during about eight hours, was fit by an exponential. The exchange times for WT, A2V, and WT:A2V, 
were 2.58 h, 1.90 h, and 2.45 h, respectively. (Right) Histogram showing the residual intensity of the major peak, 
calculated from the asymptote of the plateauing intensity after D2O → H2O exchange.
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tighter packing or less sterically-hindered interference between laterally-adjoining protofilaments or fibrils. An 
interaction of alanine2 in the WT with valine2 in the variant peptide may disrupt the fibril interactions owing to a 
mismatch of the sidechains and steric hindrance that disrupts the hydrogen-bonding and inter-sheet interactions, 
and thereby prevent fibrillogenesis, which is one of the pathological features of AD.
In summary, our x-ray and neutron diffraction experiments using magnetically aligned samples, comple-
mented by polarized light microscopy, AFM, and modeling, provide a rational basis for the paradoxical effects of 
A2V mutation in humans, explaining its aggressiveness in homozygous carriers and its prophylactic effect in het-
erozygous carriers. These findings should provide a basis for further development of A2V-modified Aβ peptides 
and peptido-mimetic molecules for therapeutic intervention in AD.
Methods
Sample preparation and wide-angle x-ray diffraction on lyophilized samples. The Aβ peptides 
were synthesized in-house using FMOC chemistry and purified by RP-HPLC (see methods and sequences below) 
purification as already described34. Neo Bio Science (Cambridge, Massachusetts) synthesized the same sequences 
to corroborate the reproducibility of the synthesis. Peptide purity was assessed by LC-MS and was always >95%.
The lyophilized peptides were gently packed into thin-walled glass capillaries of 0.7 mm (outer diam-
eter) (Charles A. Supper, Inc., South Natick, MA). All glass capillaries were siliconized with Sigmacote® 
(Sigma-Aldrich, St. Louis, MO) according to the method described previously35.
Measurements of x-ray diffraction patterns from the lyophilized samples were performed at room temperature 
using the Oxford diffraction Xcalibur PX Ultra system (Oxford Diffraction Ltd., 130 A Baker Avenue, Concord, 
MA 01742, USA)36. The CuKα X-ray beam was focused to 0.3 mm × 0.3 mm (full-width at half-maximum width 
at detector position). Spectra were collected with exposure time of 150 seconds on a two-dimensional Onyx CCD 
detector (Oxford Diffraction Inc., Concord, MA) with a sample-detector distance of 85 mm, covering the range 
for Bragg spacings d = 1.8–54 Å. After angular averaging, the background was fit by a polynomial curve to the 
intensity minima between the peaks, and subtracted. The subtracted spectra were then fit by multiple Gaussian 
peaks to measure the spacings, integral intensities, and integral widths.
Peptide synthesis and alignment of samples for neutron and synchrotron x-ray diffraction. Aβ 
synthetic peptides homologous to residues 1–28 with or without the A-to-V substitutions at position 2 (Aβ1-
28WT (WT) and Aβ1-28A2V (A2V), respectively) and Aβ synthetic peptide homologous to residues 1-6 with the 
A-to-V substitution (Aβ1-6A2V, (1-6A2V)) were synthesized by solid-phase peptide synthesis on an automated 
synthesizer (Applied Biosystems 433 A) using Fmoc-protected L-amino acid derivatives, NOVASYN-TGA resin 
on a 0.1 mM scale, and purified by reverse-phase HPLC using a Vydac Protein and Peptide C18 column (Grace 
Corporation, Passirana di Rho, Milano, IT). The purity and identity of peptides were determined by HPLC and 
MALDI-TOF analysis (model Reflex III, Bruker). Peptide purity was always above 95%.












1 6A2V(1 6A2V): DVEFRH
The lyophilized WT and A2V peptides and their 1:1 molar ratio mixture (WT:A2V) were dissolved in ddH2O 
at 10 mg/mL and dehydrated at ambient temperature for four days on a quartz support in specially designed sili-
conized (Sigmacote®) glass cylindrical cells in the presence of a 7 T static magnetic field (Fig. SI2). This procedure 
led to the formation of fibrils and their alignment along the H-bonding direction between β-strands during fiber 
formation19–21. The N-terminus 1-6A2V peptide was co-dissolved with WT in ddH2O at 4:1 molar ratio and then 
submitted to the same procedure.
To assess orientation of the amyloid fibrils prior to x-ray and neutron diffraction experiments, birefringence 
of the thin, dried pellets was monitored by polarized light microscopy21.
The sample holders were then sealed at their tops with quartz windows (Fig. SI2B), 100% D2O was introduced 
into the tubular reservoirs to re-humidify the samples, and the samples were equilibrated by storage at room tem-
perature for about 14 days prior to and during diffraction measurements.
This procedure was followed for preparing independently two sets of samples: Set I was structurally char-
acterized using neutron diffraction and x-ray diffraction; Set II was characterized using neutron diffraction for 
structure determination and for D-H hydration kinetics. The different measurements on each sample set were 
carried out within a few hours of each other. Further, high reproducibility was observed between the two sample 
sets subjected to the same measurements.
Small-angle neutron diffraction (ND) experiments were performed at D22 (Set I), and D11 (Set II) 
and wide-angle neutron diffraction was performed on D16 (Set II) at the Institut Laue-Langevin (ILL, 
Grenoble, France). Full descriptions of the instruments can be found on the ILL website (https://www.ill.eu/
instruments-support/instruments-groups/).
On the D11 and D22 beamlines, with wavelength of 4.75 Å and 4.5 Å, respectively, three sample-to-detector 
distances were selected (1.2 m, 6 m and 16 m for D11; 1.1 m, 5.6 m and 17.6 m for D22) in order to access a wide 
range of momentum transfer Q, being Q = 2π(1/d) related to the Bragg spacing of the structure, d. On D16, 
with wavelength of 4.76 Å and sample-to-detector distance 0.95 m, the corresponding Q-range was 0.01–2.5 Å−1. 
The neutron diffraction patterns were visualized and analyzed with the ILL in-house developed program LAMP. 
Intensity distributions were derived by integrating over a sector of 10° opening, and were plotted along the hori-
zontal and fiber (vertical) directions. The intensity was then radially integrated within the 10° sectors and the 
resulting scattering curves corresponding to the three sample-detector distances were merged.
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To perform D-H exchange experiments at the D16 beamline, D2O was replaced with H2O in the tubular res-
ervoir of the sample cell, which was then wax-sealed. Data were recorded during 30 hours, each point integrating 
over 15 min measurement time. The kinetics of D-H isotope replacement was estimated by recording the time 
evolution of the diffracted intensity in a Q-range corresponding to the predominant diffraction peak.
Synchrotron x-ray diffraction experiments were performed on ID02 beamline at the ESRF (Grenoble, France). 
The direct beam size was 0.3 × 0.8 mm2, the beam wavelength was 1 Å and the investigated Q-range was 0.002–
0.5 Å−1 in the Small-Angle (SAXS) configuration and Q = 0.5–3.5 Å−1 in the Wide-Angle (WAXS) configuration. 
The two configurations allowed us characterize structural parameters on different length scales from interparticle 
to intraparticle distances. For each measurement, ten frames were taken with short exposure time (0.03 s, 1 s 
dead-time) to avoid or test for radiation damage. Contribution from the empty cell was measured and subtracted 
from the intensity diffracted by each sample in both configurations. Collected images were processed and cor-
rected with the ID02 software SAXS utilities. Samples (Set I) were the same as used for the ND measurements 
on D22, and in the same siliconized glass cylindrical containers with quartz windows. Just before measurements 
on each sample, the upper quartz window was removed, and ddH2O water (3 μL) was locally added to the dry 
depositions, allowing for observable scattered x-ray intensity.
Analysis of diffraction data. First, the background curves, evaluated by fitting polynomial functions to the 
intensity minima, were subtracted from the total intensity (Fig. 1E). Diffraction data were analyzed according to 
existing models suitable for aligned fibers with a regular spatial disposition that replicates the cylindrical shapes 
of the elementary structural units37. The complex structure of the subunits and their arrangements (Fig. 1F) were 
derived as a best fit by minimizing the R-factor between the intensity observed for the sample and intensity cal-
culated for different models. The neutron scattering length density and electron density ρ →r( ) distribution in 
three-dimensional coordinates, their autocorrelation function, and the corresponding calculated intensity distri-
bution were expressed in cylindrical coordinates, and cylindrical spatial averaging was performed for the dif-
fracted intensity
= = = Φ Φ





which accounts for the shape of the fibrils (of radius r), their spatial disposition in a first circular lattice (of radius 
r0 with n0 elements), and the further arrangement in cylindrical superstructure (of radius r1 with n1 elements). 
R is the reciprocal coordinate R = Q/2π. We considered different models, corresponding to different numbers 
of fibrils (lattice points n0 and n1)38, 39 composing the circular lattice of the two-steps cylindrical arrangement. 
Polydispersity in cylinder radius was allowed, with Gaussian distribution around a mean value37 The calculated 
intensity distribution from the model was then compared with the experimental intensity distribution (after 
background subtraction and normalization) by means of a deviation R-factor
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which assessed the excess intensity due to the crystallized material as compared to the unstructured background.
Atomic Force Microscopy. Atomic force microscopy (AFM) was used to both assess the alignment of fibril-
lar aggregates of Aβ after ND experiments (Fig. 1B) and to assess the morphology of aggregates after re-suspension 
(Fig. 1G). AFM was carried out on a Multimode AFM with a Nanoscope V system operating in tapping mode, 
using standard phosphorus-doped silicon probes (Veeco/Digital Instruments, Mannheim, Germany) with a scan 
rate in the 0.5–1.2 Hz range. Freshly cleaved muscovite mica discs (Veeco/Digital Instruments) were used for 
deposition of peptide samples. To confirm the extent of alignment and to provide more detailed information on 
the orientation of fibrillar aggregates, a portion of film was detached from each of the samples used for ND exper-
iments and fixed on the surface of mica with a drop (2 µL) of ddH2O. In addition, to assess the morphology of 
the fibrillar aggregates, a piece of the dried film was taken from each of the samples, weighted, and re-suspended 
in ddH2O to an estimated final Aβ concentration of ~250 µM. After 8 hours of incubation, samples were further 
diluted to 5 µM. A 50 µL-aliquot of the resulting suspension was deposited onto mica and incubated for 2 min at 
room temperature, washed with 10 mL of water to remove the unbound sample, and dried under a gentle stream 
of nitrogen. The AFM images were analyzed by Scanning Probe Image Processor (SPIP-version-5.1.6).
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